Your wrong on 2 fronts
LGMD R4 and R2 are two different diseases in the LGMD family.
I said Sarepta is unlikely to do a trial in R2 because they don’t have the science… So what if they are doing a trial in R4.. like all their gene therapies ?
Anyway
Akki you have to realise the last announcement was successful progress
A reduction in fat within the muscle will show our drug Atl1102 works
But Science takes time and the fat results is pending.
So yes the the pumps didn’t eventuate but watch this space when the fat results are released to the market.
I agree totally with Imp.. why do you bother ?
Ann: Positive Data for ATL1102 in Limb Girdle Muscular Dystrophy, page-53
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
